• 25microgram, 50microgram, 75microgram & 100 microgram tablets

• 25microgram in 5ml, 50microgram in 5ml & 100microgram in 5ml sugar-free oral solution

• The most cost effective strength/formulation should be used

• Note: Liothyronine tablets should only be prescribed as per the following guidance:
• In line with British Thyroid Association (BTA) guidance, where levothyoroxine has failed, liothyronine may be recommended for individual patients after a carefully audited trial of at least 3 months duration of liothyronine.
• Existing patients should be reveiwed, as appropriate, by an endocrinologist to ensure the continuing need for liothyronine. Patients shouldn't have treatment stopped without review by an endocrinologist. 

Solution for injection / infusion

Approved only for patients with myxoedema coma. Not approved for routine replacement therapy. 

• 20microgram injection